12:00 AM
Jul 19, 2010
 |  BC Week In Review  |  Clinical News  |  Clinical Status

BTL-TML-HSV: Phase I/IIa start

This summer, Beech Tree will begin a placebo-controlled Phase I/IIa trial in 210 patients.

Read the full 53 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >